A review of one research paper.

Our review questions

A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers

Study review

In preparation

Not independently approved.

Paper published: 2021

Study at a glance

DOI
10.1111/jcmm.16693

Key limitation: A full assessment of this paper is not yet available. Its presence in the library does not establish benefit or safety.

0

Review in preparation

This paper has a dedicated review record, but its full study appraisal is not yet available. It has not been counted as a completed review.

0 of 15 questions answered; 0 partly resolved; 15 awaiting assessment.

The original paper and references remain available above.